The global Antibody Based Therapeutics market was valued at US$ 175410 million in 2023 and is anticipated to reach US$ 364180 million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030.

Antibody Based Therapeutics Market

Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.

The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.

This report aims to provide a comprehensive presentation of the global market for Antibody Based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Based Therapeutics.

Report Scope

The Antibody Based Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Based Therapeutics Market Report

Report Metric	Details
Report Name	Antibody Based Therapeutics Market
Accounted market size in 2023	US$ 175410 million
Forecasted market size in 2030	US$ 364180 million
CAGR	11.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Monoclonal Antibodies Bi-Specific Antibodies Therapy Antibody-drug Conjugates Other
Segment by Application	Immune Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Based Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antibody Based Therapeutics Market growing?

Ans: The Antibody Based Therapeutics Market witnessing a CAGR of 11.0% during the forecast period 2024-2030.

What is the Antibody Based Therapeutics Market size in 2030?

Ans: The Antibody Based Therapeutics Market size in 2030 will be US$ 364180 million.

Who are the main players in the Antibody Based Therapeutics Market report?

Ans: The main players in the Antibody Based Therapeutics Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Antibody Based Therapeutics Market report?

Ans: The Applications covered in the Antibody Based Therapeutics Market report are Immune Diseases, Cancer, Other

What are the Type segmentation covered in the Antibody Based Therapeutics Market report?

Ans: The Types covered in the Antibody Based Therapeutics Market report are Monoclonal Antibodies, Bi-Specific Antibodies Therapy, Antibody-drug Conjugates, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Based Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Bi-Specific Antibodies Therapy

1.2.4 Antibody-drug Conjugates

1.2.5 Other

1.3 Market by Application

1.3.1 Global Antibody Based Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Immune Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Based Therapeutics Market Perspective (2019-2030)

2.2 Antibody Based Therapeutics Growth Trends by Region

2.2.1 Global Antibody Based Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Antibody Based Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Antibody Based Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Antibody Based Therapeutics Market Dynamics

2.3.1 Antibody Based Therapeutics Industry Trends

2.3.2 Antibody Based Therapeutics Market Drivers

2.3.3 Antibody Based Therapeutics Market Challenges

2.3.4 Antibody Based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Based Therapeutics Players by Revenue

3.1.1 Global Top Antibody Based Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Antibody Based Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Antibody Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Antibody Based Therapeutics Revenue

3.4 Global Antibody Based Therapeutics Market Concentration Ratio

3.4.1 Global Antibody Based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Based Therapeutics Revenue in 2023

3.5 Antibody Based Therapeutics Key Players Head office and Area Served

3.6 Key Players Antibody Based Therapeutics Product Solution and Service

3.7 Date of Enter into Antibody Based Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Based Therapeutics Breakdown Data by Type

4.1 Global Antibody Based Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Antibody Based Therapeutics Forecasted Market Size by Type (2025-2030)

5 Antibody Based Therapeutics Breakdown Data by Application

5.1 Global Antibody Based Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Antibody Based Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Antibody Based Therapeutics Market Size (2019-2030)

6.2 North America Antibody Based Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Antibody Based Therapeutics Market Size by Country (2019-2024)

6.4 North America Antibody Based Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Based Therapeutics Market Size (2019-2030)

7.2 Europe Antibody Based Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Antibody Based Therapeutics Market Size by Country (2019-2024)

7.4 Europe Antibody Based Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Based Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Antibody Based Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Antibody Based Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Based Therapeutics Market Size (2019-2030)

9.2 Latin America Antibody Based Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Antibody Based Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Antibody Based Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Based Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Antibody Based Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Antibody Based Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Antibody Based Therapeutics Introduction

11.1.4 AbbVie Revenue in Antibody Based Therapeutics Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Antibody Based Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Antibody Based Therapeutics Introduction

11.3.4 Novartis Revenue in Antibody Based Therapeutics Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Detail

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Antibody Based Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Antibody Based Therapeutics Business (2019-2024)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Antibody Based Therapeutics Introduction

11.5.4 Roche Revenue in Antibody Based Therapeutics Business (2019-2024)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Detail

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Antibody Based Therapeutics Introduction

11.6.4 Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Detail

11.7.2 Amgen Business Overview

11.7.3 Amgen Antibody Based Therapeutics Introduction

11.7.4 Amgen Revenue in Antibody Based Therapeutics Business (2019-2024)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Antibody Based Therapeutics Introduction

11.8.4 AstraZeneca Revenue in Antibody Based Therapeutics Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Detail

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Antibody Based Therapeutics Introduction

11.9.4 Merck & Co Revenue in Antibody Based Therapeutics Business (2019-2024)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Antibody Based Therapeutics Introduction

11.10.4 Takeda Revenue in Antibody Based Therapeutics Business (2019-2024)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Detail

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Antibody Based Therapeutics Introduction

11.11.4 Merck KGaA Revenue in Antibody Based Therapeutics Business (2019-2024)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Detail

11.12.2 Seagen Business Overview

11.12.3 Seagen Antibody Based Therapeutics Introduction

11.12.4 Seagen Revenue in Antibody Based Therapeutics Business (2019-2024)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Detail

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Antibody Based Therapeutics Introduction

11.13.4 Eli Lilly Revenue in Antibody Based Therapeutics Business (2019-2024)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Detail

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Antibody Based Therapeutics Introduction

11.14.4 Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2019-2024)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Detail

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Antibody Based Therapeutics Introduction

11.15.4 Pfizer Revenue in Antibody Based Therapeutics Business (2019-2024)

11.15.5 Pfizer Recent Development

11.16 Regeneron

11.16.1 Regeneron Company Detail

11.16.2 Regeneron Business Overview

11.16.3 Regeneron Antibody Based Therapeutics Introduction

11.16.4 Regeneron Revenue in Antibody Based Therapeutics Business (2019-2024)

11.16.5 Regeneron Recent Development

11.17 Innovent

11.17.1 Innovent Company Detail

11.17.2 Innovent Business Overview

11.17.3 Innovent Antibody Based Therapeutics Introduction

11.17.4 Innovent Revenue in Antibody Based Therapeutics Business (2019-2024)

11.17.5 Innovent Recent Development

11.18 Hengrui Medicine

11.18.1 Hengrui Medicine Company Detail

11.18.2 Hengrui Medicine Business Overview

11.18.3 Hengrui Medicine Antibody Based Therapeutics Introduction

11.18.4 Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2019-2024)

11.18.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Antibody Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Bi-Specific Antibodies Therapy

Table 4. Key Players of Antibody-drug Conjugates

Table 5. Key Players of Other

Table 6. Global Antibody Based Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Antibody Based Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Antibody Based Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Antibody Based Therapeutics Market Share by Region (2019-2024)

Table 10. Global Antibody Based Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Antibody Based Therapeutics Market Share by Region (2025-2030)

Table 12. Antibody Based Therapeutics Market Trends

Table 13. Antibody Based Therapeutics Market Drivers

Table 14. Antibody Based Therapeutics Market Challenges

Table 15. Antibody Based Therapeutics Market Restraints

Table 16. Global Antibody Based Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Antibody Based Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2023)

Table 19. Ranking of Global Top Antibody Based Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Antibody Based Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Antibody Based Therapeutics Product Solution and Service

Table 23. Date of Enter into Antibody Based Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Antibody Based Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Antibody Based Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Antibody Based Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Antibody Based Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Antibody Based Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Antibody Based Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Antibody Based Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Antibody Based Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Antibody Based Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Antibody Based Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Antibody Based Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Antibody Based Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Antibody Based Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Antibody Based Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Antibody Based Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antibody Based Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antibody Based Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Antibody Based Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. AbbVie Company Detail

Table 49. AbbVie Business Overview

Table 50. AbbVie Antibody Based Therapeutics Product

Table 51. AbbVie Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Johnson & Johnson Company Detail

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Antibody Based Therapeutics Product

Table 56. Johnson & Johnson Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Novartis Company Detail

Table 59. Novartis Business Overview

Table 60. Novartis Antibody Based Therapeutics Product

Table 61. Novartis Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Gilead Sciences Company Detail

Table 64. Gilead Sciences Business Overview

Table 65. Gilead Sciences Antibody Based Therapeutics Product

Table 66. Gilead Sciences Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Gilead Sciences Recent Development

Table 68. Roche Company Detail

Table 69. Roche Business Overview

Table 70. Roche Antibody Based Therapeutics Product

Table 71. Roche Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Bristol-Myers Squibb Company Detail

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Antibody Based Therapeutics Product

Table 76. Bristol-Myers Squibb Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Development

Table 78. Amgen Company Detail

Table 79. Amgen Business Overview

Table 80. Amgen Antibody Based Therapeutics Product

Table 81. Amgen Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 82. Amgen Recent Development

Table 83. AstraZeneca Company Detail

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Antibody Based Therapeutics Product

Table 86. AstraZeneca Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 87. AstraZeneca Recent Development

Table 88. Merck & Co Company Detail

Table 89. Merck & Co Business Overview

Table 90. Merck & Co Antibody Based Therapeutics Product

Table 91. Merck & Co Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Merck & Co Recent Development

Table 93. Takeda Company Detail

Table 94. Takeda Business Overview

Table 95. Takeda Antibody Based Therapeutics Product

Table 96. Takeda Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Takeda Recent Development

Table 98. Merck KGaA Company Detail

Table 99. Merck KGaA Business Overview

Table 100. Merck KGaA Antibody Based Therapeutics Product

Table 101. Merck KGaA Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 102. Merck KGaA Recent Development

Table 103. Seagen Company Detail

Table 104. Seagen Business Overview

Table 105. Seagen Antibody Based Therapeutics Product

Table 106. Seagen Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 107. Seagen Recent Development

Table 108. Eli Lilly Company Detail

Table 109. Eli Lilly Business Overview

Table 110. Eli Lilly Antibody Based Therapeutics Product

Table 111. Eli Lilly Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 112. Eli Lilly Recent Development

Table 113. Ono Pharmaceutical Company Detail

Table 114. Ono Pharmaceutical Business Overview

Table 115. Ono Pharmaceutical Antibody Based Therapeutics Product

Table 116. Ono Pharmaceutical Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 117. Ono Pharmaceutical Recent Development

Table 118. Pfizer Company Detail

Table 119. Pfizer Business Overview

Table 120. Pfizer Antibody Based Therapeutics Product

Table 121. Pfizer Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 122. Pfizer Recent Development

Table 123. Regeneron Company Detail

Table 124. Regeneron Business Overview

Table 125. Regeneron Antibody Based Therapeutics Product

Table 126. Regeneron Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 127. Regeneron Recent Development

Table 128. Innovent Company Detail

Table 129. Innovent Business Overview

Table 130. Innovent Antibody Based Therapeutics Product

Table 131. Innovent Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 132. Innovent Recent Development

Table 133. Hengrui Medicine Company Detail

Table 134. Hengrui Medicine Business Overview

Table 135. Hengrui Medicine Antibody Based Therapeutics Product

Table 136. Hengrui Medicine Revenue in Antibody Based Therapeutics Business (2019-2024) & (US$ Million)

Table 137. Hengrui Medicine Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Antibody Based Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Antibody Based Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Bi-Specific Antibodies Therapy Features

Figure 5. Antibody-drug Conjugates Features

Figure 6. Other Features

Figure 7. Global Antibody Based Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Antibody Based Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Immune Diseases Case Studies

Figure 10. Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Antibody Based Therapeutics Report Years Considered

Figure 13. Global Antibody Based Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Antibody Based Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Antibody Based Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Antibody Based Therapeutics Market Share by Players in 2023

Figure 17. Global Top Antibody Based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Based Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Antibody Based Therapeutics Revenue in 2023

Figure 19. North America Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Antibody Based Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Antibody Based Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Antibody Based Therapeutics Market Share by Region (2019-2030)

Figure 33. China Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Antibody Based Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Antibody Based Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Antibody Based Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. AbbVie Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 48. Johnson & Johnson Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 49. Novartis Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 50. Gilead Sciences Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 53. Amgen Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 54. AstraZeneca Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 55. Merck & Co Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 56. Takeda Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 57. Merck KGaA Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 58. Seagen Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 59. Eli Lilly Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 60. Ono Pharmaceutical Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 61. Pfizer Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 62. Regeneron Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 63. Innovent Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 64. Hengrui Medicine Revenue Growth Rate in Antibody Based Therapeutics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions